Sarcopenia in the foot on magnetic resonance imaging in patients with diabetes mellitus - a systematic review.

Clinical Diabetes and Endocrinology Pub Date : 2024-10-25 DOI:10.1186/s40842-024-00194-5

Manal Ahmad, Abdulla Mohamed, Dimitri Amiras, Francesca Siracusa, Joseph Shalhoub, Alun Huw Davies

{"title":"Sarcopenia in the foot on magnetic resonance imaging in patients with diabetes mellitus - a systematic review.","authors":"Manal Ahmad, Abdulla Mohamed, Dimitri Amiras, Francesca Siracusa, Joseph Shalhoub, Alun Huw Davies","doi":"10.1186/s40842-024-00194-5","DOIUrl":null,"url":null,"abstract":"Introduction: Sarcopenia is defined by low measures of muscle quantity, quality and reduced physical performance. It is associated with higher levels of frailty. Individuals with diabetes mellitus (DM) undergo sarcopenia at an accelerated rate resulting in structural changes potentially culminating in limb loss.Aims: To review the evidence on methods of detecting and measuring sarcopenic changes on magnetic resonance imaging (MRI) in the foot in patients with diabetes.Methods: A literature review was conducted in accordance with PRISMA guidelines. We searched Embase and Medline (via Ovid), CINAHL (via Ebsco Host), Web of Science and Scopus as well as the grey literature. The MeSH terms \"sarcopenia\" AND \"diabetes mellitus\" AND \"magnetic resonance imaging\" were employed in the primary search string.Results: 874 studies were identified. 404 articles were excluded in the title and abstract screening. 33 studies were assessed for eligibility after abstract and title screening was completed by two reviewers. 7 studies evaluating sarcopenia in the foot were included in the final review.Conclusion: Sarcopenic changes are evident on MRI of the foot in patients with diabetes and is profound in patients with diabetic neuropathy. The general extent and severity of sarcopenia seems to correlate with clinical scores to assess neuropathy and is implicated in the development of diabetic foot disease.","PeriodicalId":56339,"journal":{"name":"Clinical Diabetes and Endocrinology","volume":"10 1","pages":"31"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11515346/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetes and Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40842-024-00194-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Sarcopenia is defined by low measures of muscle quantity, quality and reduced physical performance. It is associated with higher levels of frailty. Individuals with diabetes mellitus (DM) undergo sarcopenia at an accelerated rate resulting in structural changes potentially culminating in limb loss.

Aims: To review the evidence on methods of detecting and measuring sarcopenic changes on magnetic resonance imaging (MRI) in the foot in patients with diabetes.

Methods: A literature review was conducted in accordance with PRISMA guidelines. We searched Embase and Medline (via Ovid), CINAHL (via Ebsco Host), Web of Science and Scopus as well as the grey literature. The MeSH terms "sarcopenia" AND "diabetes mellitus" AND "magnetic resonance imaging" were employed in the primary search string.

Results: 874 studies were identified. 404 articles were excluded in the title and abstract screening. 33 studies were assessed for eligibility after abstract and title screening was completed by two reviewers. 7 studies evaluating sarcopenia in the foot were included in the final review.

Conclusion: Sarcopenic changes are evident on MRI of the foot in patients with diabetes and is profound in patients with diabetic neuropathy. The general extent and severity of sarcopenia seems to correlate with clinical scores to assess neuropathy and is implicated in the development of diabetic foot disease.

查看原文本刊更多论文

糖尿病患者足部磁共振成像中的 "肌少症"--系统回顾。

简介肌肉疏松症的定义是肌肉数量少、质量差和体能下降。它与较高程度的虚弱有关。目的：回顾糖尿病患者足部磁共振成像（MRI）检测和测量肌肉疏松性变化方法的相关证据：方法：根据 PRISMA 指南进行文献综述。我们检索了 Embase 和 Medline（通过 Ovid）、CINAHL（通过 Ebsco Host）、Web of Science 和 Scopus 以及灰色文献。在主要检索字符串中使用了 MeSH 术语 "肌肉疏松症"、"糖尿病 "和 "磁共振成像"：结果：共发现 874 项研究。标题和摘要筛选排除了 404 篇文章。由两名审稿人完成摘要和标题筛选后，对 33 项研究进行了资格评估。最终有 7 项评估足部肌肉疏松症的研究被纳入最终审查：结论：糖尿病患者的足部核磁共振成像显示出明显的肌肉疏松变化，而糖尿病神经病变患者的肌肉疏松程度更深。肌肉疏松症的总体范围和严重程度似乎与评估神经病变的临床评分相关，并与糖尿病足病的发展有关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Diabetes and Endocrinology

自引率

0.00%

发文量

审稿时长

8 weeks

期刊介绍： Clinical Diabetes and Endocrinology is an open access journal publishing within the field of diabetes and endocrine disease. The journal aims to provide a widely available resource for people working within the field of diabetes and endocrinology, in order to improve the care of people affected by these conditions. The audience includes, but is not limited to, physicians, researchers, nurses, nutritionists, pharmacists, podiatrists, psychologists, epidemiologists, exercise physiologists and health care researchers. Research articles include patient-based research (clinical trials, clinical studies, and others), translational research (translation of basic science to clinical practice, translation of clinical practice to policy and others), as well as epidemiology and health care research. Clinical articles include case reports, case seminars, consensus statements, clinical practice guidelines and evidence-based medicine. Only articles considered to contribute new knowledge to the field will be considered for publication.